Hemosiderosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
*There is no treatment for [[IPH]]; the mainstay of therapy is supportive care based on the [[presentation]] and [[acute]] vs. [[chronic]] nature of the patient. | *There is no [[treatment]] for [[IPH]]; the mainstay of therapy is supportive care based on the [[presentation]] and [[acute]] vs. [[chronic]] nature of the patient. | ||
*Blood transfusion should be done to correct severe anemia and shock during the acute phase. | *[[Blood transfusion]] should be done to correct severe [[anemia]] and shock during the [[acute]] phase. | ||
*Patients with acute IPH and respiratory failure secondary to alveolar hemorrhage may require invasive ventilation support. It is also recommended to consider immunosuppressive therapy in addition to high dose systemic corticosteroids in these patients. | *Patients with [[acute]] [[IPH]] and [[respiratory failure]] [[secondary]] to [[alveolar]] [[hemorrhage]] may require invasive [[ventilation]] support. It is also recommended to consider [[immunosuppressive therapy]] in addition to high [[dose]] systemic [[Corticosteroids|corticosteroids]] in these patients. | ||
* | *[[Immunosuppressants]] such as [[hydroxychloroquine]], [[azathioprine]], [[cyclophosphamide]], and [[6-mercaptopurine]] are sometimes used in combination with [[steroids]] for severe cases, or when [[steroids]] are [[contraindicated]] or not tolerated, are used. | ||
*Other treatment options with unknown efficacies include intravenous immunoglobulin (IVIG), plasmapheresis, liposteroids, and dietary modification (gluten-free diet in those with celiac disease and IPH has been shown to improve symptoms). | *Other treatment options with unknown [[Efficacy|efficacies]] include [[intravenous immunoglobulin]] ([[IVIG]]), [[plasmapheresis]], liposteroids, and [[dietary]] modification ([[gluten-free diet]] in those with [[celiac disease]] and [[IPH]] has been shown to improve [[symptoms]]). | ||
==References== | ==References== | ||
Revision as of 04:13, 28 September 2020
|
Hemosiderosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemosiderosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Hemosiderosis medical therapy |
|
Risk calculators and risk factors for Hemosiderosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is no treatment for IPH; the mainstay of therapy is supportive care based on the presentation and acute vs. chronic nature of the patient. Immuno-suppressants in combination with steroids is used for severe cases. Supportive therapy for IPH includes blood transfusion to correct severe anemia, and invasive ventilation support for respiratory failure secondary to alveolar hemorrhage.
Medical Therapy
- There is no treatment for IPH; the mainstay of therapy is supportive care based on the presentation and acute vs. chronic nature of the patient.
- Blood transfusion should be done to correct severe anemia and shock during the acute phase.
- Patients with acute IPH and respiratory failure secondary to alveolar hemorrhage may require invasive ventilation support. It is also recommended to consider immunosuppressive therapy in addition to high dose systemic corticosteroids in these patients.
- Immunosuppressants such as hydroxychloroquine, azathioprine, cyclophosphamide, and 6-mercaptopurine are sometimes used in combination with steroids for severe cases, or when steroids are contraindicated or not tolerated, are used.
- Other treatment options with unknown efficacies include intravenous immunoglobulin (IVIG), plasmapheresis, liposteroids, and dietary modification (gluten-free diet in those with celiac disease and IPH has been shown to improve symptoms).